Sun Pharma shares get a boost as its specialty biz delivers the goods
The drugmaker’s margin improvement stood out, despite some rising cost overheads in Q2
Sun Pharma also launched 22 products in domestic market, which may reflect in growth henceforth
Pharma companies have had momentum on their side since the first quarter, and Sun Pharmaceutical Industries Ltd’s Q2 numbers show the good run is continuing.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started